CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro

CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is highly contagious and presents a significant public health issue. Current therapies used to treat coronavirus disease 2019 (COVID-19) include monoclonal antibody cocktail, convalescent plasma, antivirals, immunomodulators, and anticoagu...

Full description

Bibliographic Details
Main Authors: Minh Tuyet Ma, Saiaditya Badeti, Chih-Hsiung Chen, James Kim, Alok Choudhary, Bill Honnen, Charles Reichman, David Calianese, Abraham Pinter, Qingkui Jiang, Lanbo Shi, Renping Zhou, Huanbin Xu, Qingsheng Li, William Gause, Dongfang Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Immunology
Subjects:
CAR (chimeric antigen receptor)
NK cells
COVID-19
SARS-CoV-2
N501Y variant
E484K variant
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.652223/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.652223/full

Similar Items